We’re an enthusiastic team of technical experts, creative problem solvers, and ambitious leaders working together to build impactful health products. We connect key industry players with direct-to-patient solutions that make a tangible improvement on health outcomes.
We imagine a future where our customers can more efficiently support earlier diagnosis of conditions and discover cures, where patients have better access to easy and affordable diagnostic testing services, physicians and medications, and where the world is healthier as a result of what we do.
ixlayer is the leading cloud-based platform powering an end-to-end direct to patient healthcare experience. Our technology supports operational efficiency, improves patient access, and drives better health outcomes. We seamlessly integrate services across the healthcare ecosystem simplifying and accelerating the connection to care. Our clients improve the patient experience, and drive patient engagement, while improving brand loyalty.
Our company has received industry-wide accolades and awards. Our products continue to innovate and expand, and our team are regularly featured as thought leaders.
Bringing expertise, passion, and innovation together to transform healthcare.
Pouria Sanae is a co-founder and Chief Executive Officer of ixlayer. His previous leadership roles include head of product partnership at Helix, where he led launch efforts for 22 genomics consumer products, and director of product management at Yahoo and Flickr. He was also founder and CEO of two startups – data mining company CMS (Complex Made Simple) and eCommerce platform Cityblis.
Poorya Sabounchi, PhD is a co-founder and COO of ixlayer. Previously Poorya was part of the Avantome founding team which was acquired by Illumina in 2008 where he was the key scientist inventing some of the key technologies for portable genomic sequencing technologies. Poorya has several patents and published peer-reviewed articles about DNA sequencing and pathogen detection.
Matthew Walsh, General Manager, Biopharma at ixlayer, is responsible for leading the Company’s growth strategy for the commercial Biopharma business unit. He has spent over a decade bringing innovation to commercial Biopharma teams, focused on the intersection of technology, patient analytics, and patient care
David Yu serves as the Chief Product Officer at ixlayer, drawing on over 25 years of expertise in cultivating digital products and businesses across diverse sectors, including healthcare technology, media & entertainment, fintech, and e-commerce. He spearheads the design and development of the core product and platform, aiming to accelerate the adoption of remote diagnostics by enhancing the healthcare patient experience through consumer-centric approaches.
Pooja Gulati is ixlayer’s EVP of Client Services. She is a well-rounded leader with experience developing initiatives with sales and post-sales staff, leading integration planning, implementation strategies and driving business transformations for SaaS companies.
Debra Harris is a seasoned marketing leader with a passion for revolutionizing healthcare. She currently serves as Head of Marketing at ixlayer. With over two decades of experience, Debra has honed her expertise in leading cross-functional teams, challenging the status quo in healthcare marketing.
Rohan Marr serves as ixlayer’s Head of Development. He is a seasoned technology professional with over twenty years of experience in a broad range of specialties including software engineering, executive management, product design & development, program management, microservices architecture and a proven track record of building performant, scalable teams and platforms.
Our mission began in 2017 to enable remote lab testing. Today, we operate the world’s most sought-after direct-to-patient platform — offering end-to-end services marked by an exceptional consumer experience.
Bringing Expertise, Passion, and Innovation Together to Transform Healthcare.
Moncef Slaoui served as Chief Advisor for the US government’s COVID-19 vaccine development effort, Operation Warp Speed (OPWASP). Slaoui previously spent nearly 30 years at GlaxoSmithKline (GSK), most recently as Chairman of Global Vaccines, and sat on GSK’s board from 2006 until his retirement. He also was on Moderna’s Board of Directors between 2017 and 2020 the start of Operation Warp Speed in 2020.
Paul Martino is the Co-Founder and Chief Strategy Officer of VillageMD. VillageMD is committed to offering high-quality, accessible primary care options for communities across the country through Village Medical. Prior to VillageMD, Martino was the Senior Vice President of Clinical Strategy and Innovation at Anthem/WellPoint and has held senior roles at Kaiser Permanente and Aetna.
The Honorable David J Shulkin, MD served as the ninth Secretary of the US Department of Veterans Affairs.
Prior to VA, Secretary Shulkin served as chief executive of Beth Israel in New York City and Morristown Medical Center in Northern New Jersey, Chief Medical Officer of the University of Pennsylvania Health System, the Hospital of the University of Pennsylvania, Temple University Hospital, and the Medical College of Pennsylvania Hospital, and Chairman of Medicine and Vice Dean at Drexel University School of Medicine.
Dr. Motesharei is a biopharmaceutical executive with over 25 years of industry experience focused on business development, corporate strategy, and investor relations. He has successfully executed over 100 transactions which include therapeutic product licensing and alliances, R&D collaborations, commercial product partnerships, and M&A’s. In addition, Dr. Motesharei has raised over $1B in multiple rounds of financing. Dr. Motesharei’s was recently SVP of Business & Corporate Development at Madrigal where the company received the first FDA approval for a NASH product. Since 2004, he has held similar positions with Akcea Therapeutics, EMD Serono (Merck KGaA), Dyax Corporation, Genfit, and Activx Biosciences. He has received his B.A. in Chemistry from The Colorado College and his Ph.D. in Organic Chemistry from UCLA. He completed his postdoctoral training at The Scripps Research Institute as an NIH Fellow.
Deanna Angello is an accomplished biotech executive whose experience spans biotechnology, pharmaceuticals, therapeutic platforms, and health tech companies. She is currently the Chief Commercial Officer at Cognito Therapeutics, a neurotechnology company focused on innovative treatments for Alzheimer’s and neurodegenerative diseases. Her 25+ year career across Pfizer, Genentech, Kite/Gilead, Johnson & Johnson and Springboard Enterprises has centered on building, transforming, and growing sustainable brands and businesses, from startups to Fortune 50 companies. She successfully led the commercialization and growth of multiple blockbuster therapies, collectively generating over $7 billion in revenue.
Remy Sukhija is a seasoned biopharmaceutical executive with over 25 years of experience in developing and commercializing innovative therapeutics, building high-performance organizations, and overseeing large-scale commercial operations to drive growth and profitability. Throughout his career, Remy has held key commercial leadership positions at major pharmaceutical companies like Pfizer, Biogen, and GSK, as well as C-suite roles in both private and public biotech companies. His focus has consistently been on delivering value to patients and key stakeholders.
Dr. Ban is Executive Vice President and Global Chief Medical Officer for Walgreens Boots Alliance, where he played a critical role in leading the company’s national pandemic response. In addition to providing real-time clinical guidance and implementing guidelines to ensure patient and team safety during the public health crisis, he launched and expanded COVID-19 testing and vaccination services across thousands of stores. In addition, Dr. Ban led the team that launched the Walgreens COVID-19 Index, a new tool harnessing Walgreens testing data to track new and emerging variants across the country in near real-time.
IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108
IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038
